97 related articles for article (PubMed ID: 24814870)
1. SIRT2 as a new player in epigenetic programming of keratinocyte differentiation and a candidate tumor suppressor.
Wang M; Yue Z; Paus R; Ramot Y
Exp Dermatol; 2014 Sep; 23(9):636-8. PubMed ID: 24814870
[TBL] [Abstract][Full Text] [Related]
2. Mammalian SIRT2 inhibits keratin 19 expression and is a tumor suppressor in skin.
Ming M; Qiang L; Zhao B; He YY
Exp Dermatol; 2014 Mar; 23(3):207-9. PubMed ID: 24438005
[TBL] [Abstract][Full Text] [Related]
3. High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects.
Yu J; Wu Y; Yang P
J Neurochem; 2016 May; 137(3):371-83. PubMed ID: 26896748
[TBL] [Abstract][Full Text] [Related]
4. The NAD-dependent deacetylase SIRT2 regulates T cell differentiation involved in tumor immune response.
Jiang C; Liu J; Guo M; Gao X; Wu X; Bai N; Guo W; Li N; Yi F; Cheng R; Xu H; Zhou T; Jiang B; Sun T; Wei S; Cao L
Int J Biol Sci; 2020; 16(15):3075-3084. PubMed ID: 33061819
[TBL] [Abstract][Full Text] [Related]
5. SIRT2 reduces actin polymerization and cell migration through deacetylation and degradation of HSP90.
Min JS; Kim JC; Kim JA; Kang I; Ahn JK
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1230-1238. PubMed ID: 29908203
[TBL] [Abstract][Full Text] [Related]
6. Sirtuins 1 and 2 Are Universal Histone Deacetylases.
Hsu WW; Wu B; Liu WR
ACS Chem Biol; 2016 Mar; 11(3):792-9. PubMed ID: 26820517
[TBL] [Abstract][Full Text] [Related]
7. Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation and Dysregulates Mitophagy.
Liu G; Park SH; Imbesi M; Nathan WJ; Zou X; Zhu Y; Jiang H; Parisiadou L; Gius D
Antioxid Redox Signal; 2017 May; 26(15):849-863. PubMed ID: 27460777
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation is essential for Sirt2 tumor-suppressor function in neuroblastoma.
Lu W; Wang Q; Xu C; Yuan H; Fan Q; Chen B; Cai R; Wu D; Xu M
Neoplasia; 2021 Jan; 23(1):129-139. PubMed ID: 33316537
[TBL] [Abstract][Full Text] [Related]
9. Protocols for Cloning, Expression, and Functional Analysis of Sirtuin2 (SIRT2).
Ji S; Doucette JR; Nazarali AJ
Methods Mol Biol; 2016; 1436():189-99. PubMed ID: 27246216
[TBL] [Abstract][Full Text] [Related]
10. Infection Reveals a Modification of SIRT2 Critical for Chromatin Association.
Pereira JM; Chevalier C; Chaze T; Gianetto Q; Impens F; Matondo M; Cossart P; Hamon MA
Cell Rep; 2018 Apr; 23(4):1124-1137. PubMed ID: 29694890
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.
Tiano HF; Loftin CD; Akunda J; Lee CA; Spalding J; Sessoms A; Dunson DB; Rogan EG; Morham SG; Smart RC; Langenbach R
Cancer Res; 2002 Jun; 62(12):3395-401. PubMed ID: 12067981
[TBL] [Abstract][Full Text] [Related]
12. Deacetylation of the mitotic checkpoint protein BubR1 at lysine 250 by SIRT2 and subsequent effects on BubR1 degradation during the prometaphase/anaphase transition.
Suematsu T; Li Y; Kojima H; Nakajima K; Oshimura M; Inoue T
Biochem Biophys Res Commun; 2014 Oct; 453(3):588-94. PubMed ID: 25285631
[TBL] [Abstract][Full Text] [Related]
13. The deacetylation-phosphorylation regulation of SIRT2-SMC1A axis as a mechanism of antimitotic catastrophe in early tumorigenesis.
Yi F; Zhang Y; Wang Z; Wang Z; Li Z; Zhou T; Xu H; Liu J; Jiang B; Li X; Wang L; Bai N; Guo Q; Guan Y; Feng Y; Mao Z; Fan G; Zhang S; Wang C; Cao L; O'Rourke BP; Wang Y; Wu Y; Wu B; You S; Zhang N; Guan J; Song X; Sun Y; Wei S; Cao L
Sci Adv; 2021 Feb; 7(9):. PubMed ID: 33627431
[TBL] [Abstract][Full Text] [Related]
14. Sodium butyrate, a histone deacetylase Inhibitor, ameliorates SIRT2-induced memory impairment, reduction of cell proliferation, and neuroblast differentiation in the dentate gyrus.
Yoo DY; Kim DW; Kim MJ; Choi JH; Jung HY; Nam SM; Kim JW; Yoon YS; Choi SY; Hwang IK
Neurol Res; 2015 Jan; 37(1):69-76. PubMed ID: 24963697
[TBL] [Abstract][Full Text] [Related]
15. A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection.
Eskandarian HA; Impens F; Nahori MA; Soubigou G; Coppée JY; Cossart P; Hamon MA
Science; 2013 Aug; 341(6145):1238858. PubMed ID: 23908241
[TBL] [Abstract][Full Text] [Related]
16. Multiple Roles of SIRT2 in Regulating Physiological and Pathological Signal Transduction.
Zhu C; Dong X; Wang X; Zheng Y; Qiu J; Peng Y; Xu J; Chai Z; Liu C
Genet Res (Camb); 2022; 2022():9282484. PubMed ID: 36101744
[TBL] [Abstract][Full Text] [Related]
17. Regulation of SIRT2 levels for human non-small cell lung cancer therapy.
Li Z; Xie QR; Chen Z; Lu S; Xia W
Lung Cancer; 2013 Oct; 82(1):9-15. PubMed ID: 23915912
[TBL] [Abstract][Full Text] [Related]
18. Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells.
Singh S; Kumar PU; Thakur S; Kiran S; Sen B; Sharma S; Rao VV; Poongothai AR; Ramakrishna G
Tumour Biol; 2015 Aug; 36(8):6159-71. PubMed ID: 25794641
[TBL] [Abstract][Full Text] [Related]
19. Regulation of SIRT2-dependent α-tubulin deacetylation by cellular NAD levels.
Skoge RH; Dölle C; Ziegler M
DNA Repair (Amst); 2014 Nov; 23():33-8. PubMed ID: 24814981
[TBL] [Abstract][Full Text] [Related]
20. Deacetylation of phosphoglycerate mutase in its distinct central region by SIRT2 down-regulates its enzymatic activity.
Tsusaka T; Guo T; Yagura T; Inoue T; Yokode M; Inagaki N; Kondoh H
Genes Cells; 2014 Oct; 19(10):766-77. PubMed ID: 25195573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]